Lars Møller Pedersen
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 60
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 31
- Oncology top 2%
- Viral-associated cancers and disorders 19
- Inflammatory Biomarkers in Disease Prognosis 7
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 14
-
- Medical Imaging Techniques and Applications 5
-
- Venous Thromboembolism Diagnosis and Management 8
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Nils MilmanOle GadebergFrancesco d’AmoreMichael MøllerMartin HutchingsLena SpechtAnne Kiil BerthelsenAnnika Loft
- Partner nations
- DenmarkSwedenUnited States
In The Last Decade
Lars Møller Pedersen
92 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Pathology and Forensic Medicine 2.1k
- Genetics 972
- Oncology 1.4k
- Neurology 564
- Radiology, Nuclear Medicine and Imaging 705
Countries citing papers authored by Lars Møller Pedersen
This map shows the geographic impact of Lars Møller Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Møller Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Møller Pedersen more than expected).
Fields of papers citing papers by Lars Møller Pedersen
This network shows the impact of papers produced by Lars Møller Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Møller Pedersen. The network helps show where Lars Møller Pedersen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Møller Pedersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 2 | |
| 10 | 2018 | 14 | |
| 11 | 2015 | 20 | |
| 12 | 2014 | 17 | |
| 13 | 2014 | 4 | |
| 14 | 2012 | 86 | |
| 15 | Primary refractory disease in non-Hodgkin lymphoma (NHL): Occurence, clinico-pathological features, and outcome | 2008 | 1 |
| 16 | Follicular lymphoma in young patients (>50 yrs): A population-based analysis of the Danish lymphoma registry | 2008 | 4 |
| 17 | 2007 | 287 | |
| 18 | 2003 | 10 | |
| 19 | 1996 | 198 | |
| 20 | 1992 | 4 |
About Lars Møller Pedersen
Lars Møller Pedersen is a scholar working on Pathology and Forensic Medicine, Genetics and Internal Medicine, having authored 103 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (60 papers), Chronic Lymphocytic Leukemia Research (31 papers), Viral-associated cancers and disorders (19 papers), CNS Lymphoma Diagnosis and Treatment (14 papers), Venous Thromboembolism Diagnosis and Management (8 papers), Lung Cancer Treatments and Mutations (7 papers), Inflammatory Biomarkers in Disease Prognosis (7 papers) and Medical Imaging Techniques and Applications (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Genetics (972 citations) and Oncology (1.4k citations). Lars Møller Pedersen has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Nils Milman, Ole Gadeberg, Francesco d’Amore, Michael Møller, Martin Hutchings, Lena Specht, Anne Kiil Berthelsen, Annika Loft, Mads Hansen and A. M. Boesen. Their work appears in journals such as Blood, British Journal of Haematology, Annals of Oncology, Journal of Clinical Oncology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.